Dicot Pharma AB (NGM: DICOT)

Market Cap	155.17M
Revenue (ttm)	n/a
Net Income (ttm)	-50.94M
Shares Out	817.56M
EPS (ttm)	-0.07
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,376,196
Open	0.212
Previous Close	0.207
Day's Range	0.185 - 0.212
52-Week Range	0.096 - 0.576
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 30, 2024

About Dicot Pharma AB

Dicot Pharma AB engages in the development of pharmaceutical products in Sweden. It is developing LIB-01 for the treatment of erectile dysfunction and premature ejaculation. The company was formerly known as Dicot AB (publ) and changed its name to Dicot Pharma AB in May 2024. Dicot Pharma AB was incorporated in 2015 and is based in Uppsala, Sweden.

• Industry: Pharmaceutical Preparations
• Founded: 2015
• Employees: 3
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: DICOT